Literature DB >> 17344425

Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study.

William McClellan1, Rebecca Speckman, Leslie McClure, Virginia Howard, Ruth C Campbell, Mary Cushman, Paul Audhya, George Howard, David G Warnock.   

Abstract

This report describes the prevalence and characteristics of people with a family history of ESRD in a first-degree relative (FH-ESRD). This is a cross-sectional study of individuals in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, a population-based sample of US residents who are 45 yr and older. FH-ESRD was ascertained at baseline among 12,030 participants of the cohort, and multivariate logistic regression was used to identify characteristics that were independently associated with FH-ESRD. FH-ESRD was reported by 9.5% of participants. Individual characteristics that were independently associated with FH-ESRD included black race (odds ratio [OR] 2.14; 95% confidence interval [CI] 1.82 to 2.53); female gender (OR 1.28; 95% CI 1.08 to 1.51); a history of diabetes (OR 1.22; 95% CI 1.02 to 1.47); a 1-SD change in the log of the C-reactive protein level (OR 1.10; 95% CI 1.01 to 1.19); and World Health Organization body mass index weight categories normal (OR 2.11; 95% CI 0.66 to 6.79), overweight (OR 2.64; 95% CI 0.82 to 8.42), and obese (OR 3.48; 95% CI 1.09 to 11.1) compared with underweight. Black but not white individuals with FH-ESRD were more likely to have an estimated GFR <60 ml/min per 1.73 m(2). There is a high prevalence of FH-ESRD among US adults, and the prevalence of FH-ESRD was higher among lack individuals. Individuals with a positive family history were more likely to have diabetes and to be obese. If confirmed, then these findings suggest that individuals with FH-ESRD may benefit from interventions to improve the detection and treatment of chronic kidney disease risk factors such as diabetes and obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344425     DOI: 10.1681/ASN.2006090952

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  A cross-sectional prevalence study of ethnically targeted and general audience outdoor obesity-related advertising.

Authors:  Antronette K Yancey; Brian L Cole; Rochelle Brown; Jerome D Williams; Amy Hillier; Randolph S Kline; Marice Ashe; Sonya A Grier; Desiree Backman; William J McCarthy
Journal:  Milbank Q       Date:  2009-03       Impact factor: 4.911

2.  Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care.

Authors:  Hua Hao; Brendan P Lovasik; Stephen O Pastan; Howard H Chang; Ritam Chowdhury; Rachel E Patzer
Journal:  Kidney Int       Date:  2015-04-22       Impact factor: 10.612

3.  Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup.

Authors:  Kazunobu Ichikawa; Tsuneo Konta; Ami Ikeda; Shouichi Fujimoto; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-08-05       Impact factor: 2.801

4.  Age at Immigration and Kidney Function among Self-Identified Healthy Africans in the United States.

Authors:  Mana Ali; Denée T Mwendwa; Regina Sims; Madia Ricks; Anne E Sumner
Journal:  J Immigr Minor Health       Date:  2016-02

5.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Authors:  Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

6.  Increased body mass index may be associated with greater risk of end-stage renal disease in whites compared to blacks: A nested case-control study.

Authors:  Elvis A Akwo; Kerri L Cavanaugh; Talat Alp Ikizler; William J Blot; Loren Lipworth
Journal:  BMC Nutr       Date:  2015-11-19

7.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

Review 8.  Geographic information systems and chronic kidney disease: racial disparities, rural residence and forecasting.

Authors:  Rudolph A Rodriguez; John R Hotchkiss; Ann M O'Hare
Journal:  J Nephrol       Date:  2013 Jan-Feb       Impact factor: 3.902

9.  Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease.

Authors:  Keith L Keene; Josyf C Mychaleckyj; Tennille S Leak; Shelly G Smith; Peter S Perlegas; Jasmin Divers; Carl D Langefeld; Barry I Freedman; Donald W Bowden; Michèle M Sale
Journal:  Hum Genet       Date:  2008-07-25       Impact factor: 4.132

10.  Effect of community characteristics on familial clustering of end-stage renal disease.

Authors:  Eun-Young Song; William M McClellan; Ann McClellan; Rajyalakshmi Gadi; Alexander C Hadley; Jenna Krisher; Margo Clay; Barry I Freedman
Journal:  Am J Nephrol       Date:  2009-09-30       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.